Time to TreatmentWith Endovascular Thrombectomy andOutcomes From Ischemic Stroke : AMeta-analysis

Jeffrey L. Saver, MD; Mayank Goyal, MD; Aad van der Lugt, MD; Bijoy K. Menon, MD; Charles B. L. M. Majoie, MD; Diederik W. Dippel, MD; Bruce C. Campbell, MD, PhD; Raul G. Nogueira, MD; Andrew M. Demchuk, MD; Alejandro Tomasello, MD; Pere Cardona, MD; Thomas G. Devlin, MD; Donald F. Frei, MD; Richard du Mesnil de Rochemont, MD; Olvert A. Berkhemer, MD; Tudor G. Jovin, MD; Adnan H. Siddiqui, MD, PhD; Wim H. van Zwam, MD; Stephen M. Davis, MD; Carlos Castaño, MD; Biggya L. Sapkota, MD; Puck S. Fransen, MD; Carlos Molina, MD; Robert J. van Oostenbrugge, MD; Ángel Chamorro, MD; Hester Lingsma, PhD; Frank L. Silver, MD; Geoffrey A. Donnan, MD; Ashfaq Shuaib, MD; Scott Brown, PhD; Bruce Stouch, PhD; Peter J. Mitchell, MD; Antoni Davalos, MD; Yvo B. W. E. M. Roos, MD; Michael D. Hill, MD, MS; for the HERMES Collaborators

[1]  L. Derex,et al.  Mechanical thrombectomy in acute ischemic stroke. , 2017, Revue neurologique.

[2]  A. Demchuk,et al.  Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials , 2016, The Lancet.

[3]  H. Diener,et al.  Analysis of Workflow and Time to Treatment and the Effects on Outcome in Endovascular Treatment of Acute Ischemic Stroke: Results from the SWIFT PRIME Randomized Controlled Trial. , 2016, Radiology.

[4]  A. Demchuk,et al.  Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial , 2016, Circulation.

[5]  C. Molina,et al.  Association Between Time to Reperfusion and Outcome Is Primarily Driven by the Time From Imaging to Reperfusion , 2016, Stroke.

[6]  Ewout W Steyerberg,et al.  Time to Reperfusion and Treatment Effect for Acute Ischemic Stroke: A Randomized Clinical Trial. , 2016, JAMA neurology.

[7]  R. Raman,et al.  Accuracy of First Recorded "Last Known Normal" Times of Stroke Code Patients. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[8]  Elad I Levy,et al.  Time to endovascular reperfusion and degree of disability in acute stroke , 2015, Annals of neurology.

[9]  M. Chen,et al.  Initial hospital management of patients with emergent large vessel occlusion (ELVO): report of the standards and guidelines committee of the Society of NeuroInterventional Surgery , 2015, Journal of NeuroInterventional Surgery.

[10]  C. Sorensen,et al.  Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke , 2015 .

[11]  H. Diener,et al.  Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. , 2015, The New England journal of medicine.

[12]  A. Demchuk,et al.  Thrombectomy within 8 hours after symptom onset in ischemic stroke. , 2015, The New England journal of medicine.

[13]  M. Krause,et al.  Endovascular therapy for ischemic stroke with perfusion-imaging selection. , 2015, The New England journal of medicine.

[14]  Hester F. Lingsma,et al.  A randomized trial of intraarterial treatment for acute ischemic stroke. , 2015, The New England journal of medicine.

[15]  Manabu Inoue,et al.  The Growth Rate of Early DWI Lesions is Highly Variable and Associated with Penumbral Salvage and Clinical Outcomes following Endovascular Reperfusion , 2013, International journal of stroke : official journal of the International Stroke Society.

[16]  Christopher S. Coffey,et al.  2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment , 2015 .

[17]  P. Sandercock,et al.  Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials | NOVA. The University of Newcastle's Digital Repository , 2014 .

[18]  Michael D Hill,et al.  Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial , 2014, The Lancet Neurology.

[19]  Marc Quinlan,et al.  Time to Treatment with Intravenous Tissue Plasminogen Activator and Outcome from Acute Ischemic Stroke , 2013 .

[20]  Joanna M. Wardlaw,et al.  Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke: A Consensus Statement , 2013, Stroke.

[21]  J. Broderick,et al.  Impact of Onset-to-Reperfusion Time on Stroke Mortality: A Collaborative Pooled Analysis , 2013, Circulation.

[22]  P. Meyers,et al.  Multisociety Consensus Quality Improvement Guidelines for Intraarterial Catheter-directed Treatment of Acute Ischemic Stroke, from the American Society of Neuroradiology, Canadian Interventional Radiology Association, Cardiovascular and Interventional Radiological Society of Europe, Society for Card , 2013, AJNR. American journal of neuroradiology.

[23]  V. Howard,et al.  A Simple, Assumption-Free, and Clinically Interpretable Approach for Analysis of Modified Rankin Outcomes , 2012, Stroke.

[24]  J. Grotta,et al.  Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window: Joint Outcome Table Analysis of the ECASS 3 Trial , 2009, Stroke.

[25]  J. Saver Time Is Brain—Quantified , 2006, Stroke.

[26]  W. Hacke,et al.  Hemorrhagic Transformation of Ischemic Brain Tissue: Asymptomatic or Symptomatic? , 2001, Stroke.

[27]  Joseph P. Broderick,et al.  Effects of tissue plasminogen activator for acute ischemic stroke at one year , 1999 .